Skip to content
TrialScanner

NCT01072812

Study of the Pharmacokinetics and Pharmacodynamics of POSIPHEN® in Subjects With Amnestic Mild Cognitive Impairment

Phase 1TerminatedANVSLead

Registry record

Lead sponsor
Annovis Bio Inc.
Conditions
Alzheimer's Disease; Amnestic Mild Cognitive Impairment
Primary completion
Jul 2010Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT01072812 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT01072812: Study of the Pharmacokinetics... | TrialScanner